Application Nr Approved Date Route Status External Links
NDA213150 None None None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Fensolvi Is Indicated For The Treatment Of Pediatric Patients 2 Years Of Age And Older With Central Precocious Puberty (Cpp). Fensolvi Is A Gonadotropin Releasing Hormone (Gnrh) Agonist Indicated For The Treatment Of Pediatric Patients 2 Years Of Age And Older With Central Precocious Puberty.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Leuprolide Acetate

Comments